share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(33.85%),Matthew Friesen(33.85%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(33.85%),Matthew Friesen(33.85%), etc.

Bruush Oral Care | SC 13D/A:超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(33.85%),Matthew Friesen(33.85%)等
美股SEC公告 ·  02/17 06:18
牛牛AI助理已提取核心訊息
On February 9, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant ownership stake in Bruush Oral Care Inc. The filing reveals that the group collectively holds approximately 33.85% of Bruush Oral Care's common shares, which includes 43,000,000 common shares issuable upon the exercise of Pre-Funded Warrants and Side Letter Warrants. The Friesens, both Canadian citizens, have substantial control over the investment decisions of Yaletown Bros. Ventures Ltd. The filing also details a recent transaction where the Reporting Persons provided Bruush Oral Care with an additional $200,000 in funding, in exchange for a Side Letter Warrant to purchase 10,000,000 common shares at $0.001 per share...Show More
On February 9, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant ownership stake in Bruush Oral Care Inc. The filing reveals that the group collectively holds approximately 33.85% of Bruush Oral Care's common shares, which includes 43,000,000 common shares issuable upon the exercise of Pre-Funded Warrants and Side Letter Warrants. The Friesens, both Canadian citizens, have substantial control over the investment decisions of Yaletown Bros. Ventures Ltd. The filing also details a recent transaction where the Reporting Persons provided Bruush Oral Care with an additional $200,000 in funding, in exchange for a Side Letter Warrant to purchase 10,000,000 common shares at $0.001 per share. The Reporting Persons' ownership interest in Bruush Oral Care is primarily for investment purposes, but they reserve the right to take further action regarding their holdings based on market conditions and the company's performance. The amendment to Schedule 13D follows a series of transactions between October 11, 2023, and October 24, 2023, where the Reporting Persons' ownership ranged from 63% to 82% of the company's securities.
2024年2月9日,Yaletown Bros. Ventures Ltd和個人Matthew Friesen以及Bradley Friesen,向美國證券交易委員會提交了Schedule 13D的修正案,標明瞭對Bruush Oral Care Inc的重要持股。文件顯示,該組合共持有Bruush Oral Care約33.85%的普通股,其中包括4300萬股可由Pre-Funded Warrants和Side Letter Warrants行權。加拿大公民Friesens對Yaletown Bros. Ventures Ltd的投資決策具有實質性控制權。提交的文件還詳細說明了最近一次交易,...展開全部
2024年2月9日,Yaletown Bros. Ventures Ltd和個人Matthew Friesen以及Bradley Friesen,向美國證券交易委員會提交了Schedule 13D的修正案,標明瞭對Bruush Oral Care Inc的重要持股。文件顯示,該組合共持有Bruush Oral Care約33.85%的普通股,其中包括4300萬股可由Pre-Funded Warrants和Side Letter Warrants行權。加拿大公民Friesens對Yaletown Bros. Ventures Ltd的投資決策具有實質性控制權。提交的文件還詳細說明了最近一次交易,即報告人提供了額外的200,000美元資金給Bruush Oral Care,以換取購買1000萬普通股的Side Letter Warrant,每股價格爲0.001美元。報告人對Bruush Oral Care的持股興趣主要是投資目的,但他們保留根據市場條件和公司表現採取進一步行動的權利。Schedule 13D的修訂是在2023年10月11日至2023年10月24日之間的一系列交易之後,報告人對該公司的持股比例在63%至82%之間。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。